Private Wealth Advisors, LLC Abb Vie Inc. Transaction History

Private Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $180,079 - $208,468	1,348 New	1,348 $200,000
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $723 - $832	5 Added 0.37%	1,349 $214,000
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $185,888 - $222,929	1,344 New	1,344 $217,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $182,208 - $231,647	-1,324 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$131.98 - $163.75 $174,741 - $216,805	1,324 New	1,324 $215,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $1.23 Million - $1.55 Million	-11,418 Closed	0 $0
Q3 2021 Dec 03, 2021	SELL	$106.4 - $120.78 $9,788 - $11,111	-92 Reduced 0.8%	11,418 $1.33 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $130,565 - $145,457	1,241 Added 12.08%	11,510 $1.3 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.05 Million - $1.16 Million	10,269 New	10,269 $1.11 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Private Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Wealth Advisors, LLC with notifications on news.